All News

President Trump signed into law HR 2483, also known as the SUPPORT for Patients and Communities Reauthorization Act of 2025.

Multifaceted antimicrobial stewardship initiatives significantly enhance antibiotic prescribing practices for respiratory infections, improving patient outcomes.

Researchers explore community-acquired pneumococcal-related hospital admissions among adults from 2000 to 2019 and assess pneumococcal immunization’s impact after the year 2015.

In an exploration of the National Retail Data Monitor, researchers determine how OTC sales contributed to disease surveillance.

Person-centric packaging enhances medication adherence for type 2 diabetes patients, simplifying therapy and improving outcomes, according to recent studies.

John C. Goodman, PhD, discusses TrumpRx’s impact on patients and pharmacies, comparing this administration’s approach with the previous Biden Administration.

Dietary nutrients show promise in reducing asthma risk linked to indoor air pollution, offering new strategies for pharmacists in patient care.

The agency’s findings spur promises of significant change to the development and recommendations surrounding various immunizations.

Researchers investigate serotype distribution and antimicrobial resistance among children in Mexico with pneumococcal meningitis.

Conflicting federal health guidance creates confusion and erodes public trust, impacting patient safety and access to vital medical interventions.

Researchers conduct a cost-effectiveness analysis to uncover the public health and economic impacts of PCV20 among Australian children.

Novo Nordisk announced results of the evoke and evoke+ phase 3 trials on semaglutide’s use in treating Alzheimer disease progression.

Key sessions from the National Community Pharmacists Association 2025 Annual Convention & Expo highlight pharmacy benefit manager reform, pneumococcal vaccines, and billable services.

Tardive dyskinesia presents significant challenges for patients, but new FDA-approved treatments offer hope for improved management and quality of life.

Catie Stimmel, PharmD, explores the confidentiality and non-punitive processes that are crucial in driving value toward patient safety organizations.

Experts at the Milken Institute address better ways of adopting pharmacy services within the greater health care ecosystem.

After nearly 20 years of pneumococcal conjugate vaccine use in the Portuguese vaccine schedule, researchers explore serotype distribution in bacteria causing adult invasive pneumococcal disease (IPD).

The CDC states that the claim “vaccines do not cause autism” is not evidence based because studies have not ruled out the possibility that infant vaccines cause autism.

Regeneron Pharmaceuticals’ newest drug will be the first and only approved flexible treatment option for retinal vein occlusion.

The FDA approves denosumab biosimilars Osvyrti and Jubereq, expanding treatment options for osteoporosis and bone-related conditions.

A study reveals declining support for COVID-19 measures over time, highlighting the critical role of pharmacists in providing essential health education.

Patients tend to trust their physician to deprescribe more than their community pharmacist.

Pharmacists enhance diabetes care through text messaging interventions, improving medication adherence and glycemic control in patients with complex treatment plans.

Researchers explore the no-cost uptake of 2 separate emergency contraception methods.

Study authors explore online purchasing habits for prescription-only and OTC medications.

A study reveals first-trimester SARS-CoV-2 infection increases neonatal risks and highlights disparities in testing among pregnant women across demographics.

Researchers explore OTC medication misuse among adults over 65 in Saudi Arabia.

A recent review highlights cardiovascular risks linked to albuterol use in asthma treatment, urging safer alternatives and enhanced patient monitoring strategies.